Inside the scientific trial practical experience with Xyrem in narcolepsy/cataplexy patients at therapeutic doses, two sufferers claimed stress and a single described insomnia subsequent abrupt discontinuation within the termination from the clinical trial; in the two patients with stress and anxiety, the frequency of cataplexy had enhanced markedl